post-add

Articles for Finance

Healthtech Platform ‘WatchYourHealth’ Raises USD 2.2 Mn

The company said the new round of funding in FY23 will fuel the next phase of WYH's growth and expansion plans. The funds will be allocated towards product development, geographic expansion, sales and marketing efforts, office spaces, and inventory enhancement

Read More
Lupin Gets USD 25 Mn From Abbvie To Begin Phase 1 Clinical Studies For Cancer Drug

Lupin and AbbVie inked the licensing, development, and commercialization agreement in 2018 for this novel oncology drug to treat Hematological Cancers

Read More
Eye Mantra Secures USD 10 Mn Investment From MantraCare

Eye Mantra, a leading eye care chain, is thrilled to announce a significant investment of USD 10 million from MantraCare, a prominent global healthcare player. This funding will fuel the expansion of Eye Mantra's branch network across India, with a vision to establish a presence in more than 30 cities

Read More
Fortis Healthcare Divests Vadapalani Facility To Kauvery Hospitals For 152 Cr

Fortis Healthcare, a leading healthcare delivery service provider in India on Thursday signed a definitive agreement to sell its hospital business operations at Vadapalani, Chennai to Sri Kauvery Medical Care for a sale consideration of Rs 152 Crore, the company said in an exchange filing

Read More
Total Funding In Healthtech Plunged 55% In 2022 To $1.4 Bn

Total funding in the healthtech companies in India plunged 55 per cent from USD 3.2 billion in 2021 to USD 1.4 billion in 2022 revealed in a report on the Indian HealthTech sector by LoEstro Advisors on Tuesday

Read More
Siemens Plans To Invest $2.2 Bn To Ramp Global Production

Siemens will spend 2 billion euros (USD 2.16 billion) on a new global investment plan, the German engineering and technology group said on Thursday, as it gears up to meet increased demand triggered by global stimulus packages

Read More
Glenmark Slashes Cost Of Breast Cancer Drug Trastuzumab In India

Glenmark Pharmaceuticals, the global pharmaceutical company on Thursday restructured the price of Trastuzumab drug indicated for HER2‐positive breast cancer. A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country, the company said in a statement

Read More
France To Invest $35 Mn In Quadria Capital, A Healthcare-focused Private Equity

Proparco, a unit of France's state development agency, is making a USD 35 million equity investment in Quadria Capital, an Asia healthcare-focused private equity firm, the companies said on Tuesday, to develop healthcare facilities in the region

Read More

Subscribe to our newsletter to get updates on our latest news